Total Payments
$21,782
2024 Payments
$2,771
Companies
78
Transactions
1,438
Medicare Patients
4,062
Medicare Billing
$806,502
Payment Breakdown by Category
Food & Beverage$21,334 (97.9%)
Other$215.18 (1.0%)
Education$209.50 (1.0%)
Consulting$23.27 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,334 | 1,424 | 97.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $215.18 | 10 | 1.0% |
| Education | $209.50 | 3 | 1.0% |
| Consulting Fee | $23.27 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,699 | 100 | $0 (2024) |
| Allergan, Inc. | $1,641 | 109 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $1,613 | 188 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,504 | 135 | $0 (2024) |
| GENZYME CORPORATION | $1,389 | 78 | $0 (2024) |
| Celgene Corporation | $1,135 | 60 | $0 (2024) |
| Biogen, Inc. | $1,031 | 62 | $0 (2024) |
| UCB, Inc. | $1,024 | 60 | $0 (2024) |
| Genentech USA, Inc. | $929.43 | 63 | $0 (2024) |
| Amgen Inc. | $910.37 | 48 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,771 | 121 | ABBVIE INC. ($429.01) |
| 2023 | $2,563 | 137 | ABBVIE INC. ($448.41) |
| 2022 | $3,020 | 182 | ABBVIE INC. ($416.24) |
| 2021 | $3,523 | 242 | Allergan, Inc. ($351.88) |
| 2020 | $3,101 | 223 | Allergan, Inc. ($573.58) |
| 2019 | $3,056 | 222 | Novartis Pharmaceuticals Corporation ($508.09) |
| 2018 | $2,117 | 174 | GENZYME CORPORATION ($301.56) |
| 2017 | $1,632 | 137 | GENZYME CORPORATION ($257.36) |
All Payment Transactions
1,438 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Cycle Pharmaceuticals Inc | Tascenso ODT (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.86 | General |
| Category: Neuroscience | ||||||
| 12/18/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Neurology | ||||||
| 12/12/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.59 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $32.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.01 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.80 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.87 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.87 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 931 | 17,269 | $1.2M | $210,671 |
| 2022 | 15 | 1,130 | 16,367 | $1.3M | $233,672 |
| 2021 | 14 | 1,110 | 12,897 | $1.1M | $205,580 |
| 2020 | 14 | 891 | 9,453 | $824,583 | $156,579 |
Total Patients
4,062
Total Services
55,986
Medicare Billing
$806,502
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 27 | 16,000 | $384,000 | $78,716 | 20.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 241 | 352 | $277,376 | $44,796 | 16.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 137 | 137 | $133,712 | $21,512 | 16.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 186 | $83,509 | $17,715 | 21.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 98 | 103 | $89,633 | $14,214 | 15.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 26 | 80 | $61,760 | $10,071 | 16.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 91 | $51,142 | $8,321 | 16.3% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 25 | 27 | $27,567 | $5,479 | 19.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 194 | 194 | $14,938 | $3,453 | 23.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 49 | $15,288 | $3,102 | 20.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 18 | 30 | $13,686 | $2,413 | 17.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 20 | 20 | $6,254 | $879.20 | 14.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 25 | 14,800 | $355,200 | $70,708 | 19.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 237 | 361 | $284,468 | $47,417 | 16.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 183 | 183 | $178,608 | $30,121 | 16.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 103 | 258 | $115,658 | $21,130 | 18.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 113 | 121 | $105,293 | $19,190 | 18.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 25 | 73 | $56,286 | $9,292 | 16.5% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 36 | 36 | $37,651 | $7,262 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 77 | $43,274 | $7,161 | 16.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 33 | 56 | $24,248 | $4,429 | 18.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 78 | $24,336 | $4,418 | 18.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 241 | 241 | $18,557 | $4,341 | 23.4% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 14 | 22 | $17,998 | $3,256 | 18.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 12 | 12 | $11,520 | $2,056 | 17.8% |
About Dr. Sunil Kumar Reddy, M.D
Dr. Sunil Kumar Reddy, M.D is a Neurology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952368433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sunil Kumar Reddy, M.D has received a total of $21,782 in payments from pharmaceutical and medical device companies, with $2,771 received in 2024. These payments were reported across 1,438 transactions from 78 companies. The most common payment nature is "Food and Beverage" ($21,334).
As a Medicare-enrolled provider, Reddy has provided services to 4,062 Medicare beneficiaries, totaling 55,986 services with total Medicare billing of $806,502. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Tampa, FL
- Active Since 04/27/2006
- Last Updated 03/25/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1952368433
Products in Payments
- BOTOX (Biological) $1,577
- ZEPOSIA (Drug) $1,389
- Aimovig (Biological) $865.83
- UBRELVY (Drug) $796.00
- OCREVUS (Biological) $705.63
- AUBAGIO (Drug) $616.49
- AJOVY (Biological) $541.88
- Neupro (Drug) $531.20
- NURTEC ODT (Drug) $514.59
- TROKENDI XR (Drug) $473.39
- GILENYA (Drug) $454.23
- TYSABRI (Biological) $448.48
- AIMOVIG (Biological) $444.23
- KESIMPTA (Drug) $399.35
- UPLIZNA (Drug) $388.33
- AJOVY (Drug) $378.95
- NUEDEXTA (Drug) $366.87
- LEMTRADA (Drug) $358.27
- VYEPTI (Biological) $334.59
- AUSTEDO (Drug) $319.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Tampa
Derrick Robertson, M.d, M.D
Neurology — Payments: $2.3M
Neurology $2.3M
Selim Benbadis, Md, MD
Neurology — Payments: $2.3M
Neurology $2.3M
Dr. Mark Cascione, M.d, M.D
Neurology — Payments: $1.9M
Neurology $1.9M
Robert Hauser, Md, MD
Neurology — Payments: $1.5M
Neurology $1.5M
David Rose, M.d, M.D
Neurology — Payments: $1.5M
Neurology $1.5M
Dr. Katherine Standley, Do, DO
Neurology — Payments: $1.3M
Neurology $1.3M